As we have confirmed that TRIM65 functioned as an oncogene in RCC, we then use full-length human TRIM65 protein as the bait in a yeast-two-hybrid assay to screen for the interacting protein candidates and explore the underlying mechanism. The gene discussed is TRIM65; the disease is renal cell carcinoma.